XXXX : a long-term follow-up study.

@entity1 @entity3551 @entity3807 @entity5507 @entity3885 @entity134 @entity230 @entity1002
Eleven @entity1 (8 male) with @entity3807 ( @entity3807 ) were reviewed. The mean age of the @entity1 was 44 years. Five @entity1 (group 1) who had moderate @entity3885 were treated only by @entity230 . Six @entity1 (group 2) who presented with @entity3551 (and/or serious metabolic disturbances) were treated with a combination of surgery and @entity134 administration. Unilateral or bilateral ureterolysis was performed in 5 @entity1 . It was associated with nephrostomy in 2 cases and intraperitoneal disposition of the ureters in 1 case. @entity1002 without ureterolysis was performed in 1 @entity1 . The mean follow-up period was 5.5 years (5 months to 20 years). All @entity1 of group 1 now have normal renal function. In 5 @entity1 of group 2, renal function improved significantly after operation; one of them was started on regular dialysis 16 years later. In another @entity1 , @entity3807 recurred in the ureter of a living related renal graft 6 months after transplantation. In conclusion, @entity134 treatment alone offers a long-term survival in @entity1 with @entity3807 of moderate severity. Combined treatment must be recommended for @entity1 who present with severe @entity3885 and advanced @entity5507 .
